申请人:Eli Lilly and Company
公开号:US07855211B2
公开(公告)日:2010-12-21
The present invention provides a compound of formula (I):
or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.
本发明提供了式(I)的化合物:或其药学上可接受的盐,其在细胞增殖性疾病的治疗中有用。